tiprankstipranks
Trending News
More News >
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market
Advertisement

Taysha Gene Therapies (TSHA) Revenue

Compare
1,221 Followers

Taysha Gene Therapies Revenue

Taysha Gene Therapies had a revenue of 0.00 in the quarter ending Sep 30, 2025, with -100.00%. This bring the company's revenue in the last twelve months to 6.31M, Increased -22.08%. In the fiscal year ending Dec 31, 2024, Taysha Gene Therapies had annual revenue of 8.33M with -46.07% growth.
Revenue (ttm)
6.31M
Revenue Growth
-36.36%
P/S Ratio
159.76
Revenue/Employee
$114,151
Employees
73
Market Cap
$1.33B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
8.33M-7.12M+53.93%
Dec 31, 2023
15.45M12.95M+617.55%
Dec 31, 2022
2.50M-250,200,000.00%
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis